No Data
Harmonic, Mitsui a-reit etf, etc
Harmonic <6324> mass production of decelerators for humanoid robots, strategic investment of 10 billion yen (Nikkan Kogyo newspaper) - ○ GL Techno <255A> domestically returning quartz glass for semiconductor equipment, successive new factories (Nikkan Kogyo newspaper) - ○ Mitsui A-REIT ETF <8801> with Nippon Steel Kowa Real Estate, large logistics facility in Itabashi, Tokyo (Nikkan Kogyo newspaper) - ○ Sony Group Corp <6758> acquires Pink Floyd music rights for 58 billion yen (Nikkan Kogyo newspaper) - ○ IDEC <6652> releases easy-to-use safety control equipment, prog
Three points to focus on in the morning session~ Strong buying interest targeting pullbacks in the context of a weak yen trend~
In the morning of the 3rd trading day, we want to focus on the following three points: - Amidst the trend of yen depreciation, there is strong buying interest waiting for pullbacks - Seibu HD, upward revision on 3/25, operating profit 45 billion yen ← 40 billion yen - Morning focus material: harmonic, mass production of decelerators for humanoid robots, strategic investment of 10 billion yen Amidst the trend of yen depreciation, there is strong buying interest waiting for pullbacks. In the Japanese stock market on the 3rd, after a round of buying, there may be a stalemate, but a market development with strong buying interest for pullbacks is expected. On the 2nd, the US
YS Food, etc. [Stocks with unique value seen from volume changes]
Stock Closing Price Change From Previous Day Volume <4892> Scifuse 617 14 562,800 <4317> Ray 440 12 59,800 <2518> NF Japan Women's Acitve 1581 25 22,633 <2555> Tokyo Stock Exchange REIT ETF 1822 11 18,890 <1730> Asou Foam 608
Noil Immun, Carna Bio, and others.
Special profit from the sale of stocks of affiliated companies <3908> expected to be included as special profit at 0.064 billion yen <4572> Issuance of new shares through third-party allocation (1,05600 shares) <4892> Subsidy income from Saifuze of approximately 0.1.4 billion yen expected to be included as non-operating income <4893> Business alliance with Takarabio <4974> in the development of Noil Immune NIB103 <7776> Expected delay in the start date of Cell Seed's homogeneous cartilage cell sheet (CLS2901C) clinical trial
Jelly Beans Group, Siphuse, etc.
<2164> Region Newspaper Co., Ltd. Shareholding ratio 9.95% → 9.95% Reporting obligation start date 2024/09/09 <3070> Jelly Beans Group Milestone Capital Management Co., Ltd. Shareholding ratio 8.12% → 7.43% Reporting obligation start date 2024/09/06 <4892> Cyfuse SBI Ventures Two Co., Ltd. Shareholding ratio
Insider decrases its stake in Cyfuse Biomedical KK(4892.JP) to 11.11%
On Sep 11, SBI Ventures Two株式会社 and related parties submitted the Change Report to Ministry of Finance. The report shows that SBI Ventures Two株式会社 and related parties decreased their holdings in $
No Data
No Data